VolitionRx

Beyond's analysis on VolitionRx

• 2026-09-14 — VolitionRx eliminates $7.5 million debt overhang via full cash pre-payment of convertible note

Recent news mentioning VolitionRx

• 2026-09-17 — VolitionRx Shares Further Details and Video of the DETECSEPS Program Launch in France
• 2026-09-17 — VolitionRx Participates in Launch of DETECSEPS Program in France
• 2026-09-14 — VolitionRx Limited Announces Pre-Payment in Full of $7.5 million Senior Secured Convertible Promissory Note Due May 20, 2027
• 2026-08-26 — VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets
• 2026-08-13 — VolitionRx Limited Announces Second Quarter 2026 Financial Results and Business Update
• 2026-08-11 — VolitionRx Limited Schedules Second Quarter 2026 Earnings Conference Call and Business Update

Appears alongside

• France

Browse the full archive →